Athos Capital »

Amicus Therapeutics shares owned by Athos Capital

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by Athos Capital from 13F filings

Historical chart of Athos Capital investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Athos Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Athos Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $8.5M 600k 14.24

More positions owned by Athos Capital

Kenvue (KVUE)
Hello Group Ads (MOMO)
Ke Hldgs Sponsored Ads (BEKE)
Avidity Biosciences Ord (RNA)
Hologic (HOLX)
Clearwater Analytics Hldgs I Cl A Call Option (CWAN)
Chart Industries (GTLS)
Cidara Therapeutics Com New (CDTX)
Amicus Therapeutics (FOLD)
PNM Resources (TXNM)
Liberty Broadband Corp Com Ser C (LBRDK)
Norfolk Southern (NSC)
Janus Henderson Group Ord Shs (JHG)
Joyy Ads Repstg Com A (JOYY)
Confluent Class A Com (CFLT)

View all positions for Athos Capital

Top funds holding Amicus Therapeutics

Vanguard Group
Wellington Management Company
BlackRock
State Street Corporation
Millennium Management
Bellevue Group
William Blair Investment Management
Vestal Point Capital
Citadel Advisors
Geode Capital Management
Perceptive Advisors
Goldman Sachs Group
UBS Group
Palo Alto Investors
Soleus Capital Management

View all funds holding Amicus Therapeutics